Showing results (461-470 of 1,510) with videos related to
Sort By:
Pageof 151
Pharmacology & Therapeutics|March 29, 2011
Serotonin receptors and heart valve disease--it was meant 2BJoshua D Hutcheson, Vincent Setola, Bryan L Roth, et al.Developmental Psychobiology|August 3, 2017
Phenotypic outcomes in adolescence and adulthood in the scarcity-adversity model of low nesting resources outside the home cageTiffany S Doherty, Jennifer Blaze, Samantha M Keller, et al.Journal of the American Veterinary Medical Association|January 15, 1986
Clostridial peritonitis associated with a mast cell tumor in a dogD M Clark, H J Harvey, L Roth, et al.Biochemical Pharmacology|May 8, 1992
Cocaethylene hepatotoxicity in miceS M Roberts, L Roth, R D Harbison, et al.Hormone Research|December 7, 2007
Type 2 diabetes in children and adolescents in a 2-year follow-up: insufficient adherence to diabetes centersThomas Reinehr, Edith Schober, Christian L Roth, et al.European Journal of Pharmacology|December 9, 2003
Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonistSrinivas Peddi, Bryan L Roth, Richard A Glennon, et al.Reproduction in Domestic Animals = Zuchthygiene|January 3, 2013
Factors influencing annual fecal testosterone metabolite profiles in captive male polar bears (Ursus maritimus)E Curry, T L Roth, K M MacKinnon, et al.Nature Methods|January 8, 2013
A pharmacological organization of G protein-coupled receptorsHenry Lin, Maria F Sassano, Bryan L Roth, et al.Applied and Environmental Microbiology|June 1, 1997
Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stainB L Roth, M Poot, S T Yue, et al.Bipolar Disorders|March 17, 2001
A theoretical reappraisal of mixed states: dysphoria as a third dimensionA Dayer, J M Aubry, L Roth, et al.Pageof 151